IPXL Financial Facts

Total revenues: 225.51M
Cost of revenues: 122.92M
See Full Income Statement

Accounts receivable, net: 214.45M
Cash and cash equivalents: 412.18M
See Full Balance Sheet

Impax Laboratories Inc. (IPXL) Earnings

  |   Expand Research on IPXL
Next EPS Date 8/9/16 EPS Growth Rate -2.9%
Average EPS % Beat Rate +12.7% Revenue Growth Rate +5.0%
Average % Move 1-Wk after EPS +2.4% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/9/16 Q216 N/A$0.33 N/A N/A$224.97M N/A N/A N/A
5/10/16 Q116 $0.43$0.39 +$0.04$226M$247.2M N/A Details
2/22/16 Q415 $0.62$0.44 +$0.18$282.1M$223.23M N/A Details
11/9/15 Q315 $0.40$0.39 +$0.01$221.1M$214.69M N/A Details
8/10/15 Q215 $0.34$0.35 -$0.01$214.2M$199.93M N/A Details
5/11/15 Q115 $0.09$0.18 -$0.09$143.1M$146M N/A Details
2/24/15 Q414 $0.16$0.12 +$0.04$131.2M$125.5M N/A Details
11/4/14 Q314 $0.33$0.31 +$0.02$158M$148.36M N/A Details